Brightflow develops cardiac medical devices and assistance services designed to treat heart failures.
Brightflow has raised $18.2M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Brightflow's investors include GO CAPITAL, Karista, BNP Paribas Développement, UI Investissement, VIVES Funds.
Brightflow is headquartered in Paris, France.
Brightflow develops cardiac medical devices and assistance services designed to treat heart failures.
Brightflow is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brightflow — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/brightflow. Accessed September 23, 2026.
VCBacked. (2024). Brightflow — Funding & Investors. Retrieved September 23, 2026, from https://www.vcbacked.co/company/brightflow
{{cite web |title=Brightflow — Funding & Investors |url=https://www.vcbacked.co/company/brightflow |website=VCBacked |access-date=September 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated